loader2
Partner With Us NRI

Vivo Bio Tech Ltd share Price Today

Company details

44.00
45.94
21.05
56.00
6M Return 19.08%
1Y Return 81.83%
Mkt Cap.(Cr) 66.23
Volume 12,763
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 12,763

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Vivo Bio Tech Ltd shares SWOT Analysis

Strengths (8)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Company with high TTM EPS Growth
  • Companies with rising net profit margins - quarterly as well as TTM basis

Weakness (1)

  • Declining Net Cash Flow : Companies not able to generate net cash

Opportunity (1)

  • Highest Recovery from 52 Week Low

Threats (2)

  • Companies with growing costs YoY for long term projects
  • Increasing Trend in Non-Core Income

Resistance and support

R1 45.7
R2 46.8
R3 47.7
Pivot

44.87

S1 43.8
S2 42.9
S3 41.9
EMA SMA
44.7
43.4
41.0
37.8
44.3
43.9
40.4
35.9
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
MORE AGRISUPPLIES & SERVICES PRIVATE LIMITED Bulk Sell 2022-04-26 40.06 82812 BSE
VEAN SMART INFRA PRIVATE LIMITED Bulk Sell 2022-02-15 36.75 102900 BSE
VEAN SMART INFRA PRIVATE LIMITED Bulk Sell 2022-02-14 41.05 126031 BSE
Name Category Shares
KOMPELLA MADHAVI LATHA PROMOTER 1.68%
KOMPELLA VISWANATH PROMOTER 1.01%
CRYPTOLOGIC SYSTEMS PRIVATE LIMITED PROMOTER 9.02%
MAXCELL PHONES COMMUNICATIONS INDIA PRIVATE LIMITED PROMOTER 8.05%
SHRI SHRI RESORTS PVT LTD PROMOTER 7.16%
IRAGAVARAPU CONSTRUCTIONS PRIVATE LIMITED PROMOTER 6.71%
IRON AGE INDIA LTD PROMOTER 4.03%
PKI SOLUTIONS PRIVATE LIMITED PROMOTER 4.03%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Vivo Bio Tech Ltd Stocks COMPARISON

Financials( in Cr) Vivo Bio Tech Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Dr Reddys Laboratories Ltd Divis Laboratories Ltd
Price 44.44 1,537.55 1,375.20 6,050.35 3,764.20
% Change -2.20 -0.16 -0.45 0.66 1.28
Mcap Cr 66.23 368,909.75 111,026.77 100,925.28 99,927.84
Revenue TTM Cr 52.23 43,885.68 15,790.60 24,669.70 7,767.51
Net Profit TTM Cr 2.65 8,560.84 2,513.47 4,507.30 1,823.38
PE TTM 17.24 39.31 28.09 19.31 72.26
1 Year Return 81.83 53.96 51.71 24.69 19.02
ROCE 10.97 16.79 14.76 25.99 19.30
ROE 5.35 16.46 10.66 21.21 14.89
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 51.87 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 27,985.89 -4,210.70
LAST 3M 85,258.15 42,414.35
LAST 6M 136,201.24 75,801.89
LAST 12M 211,048.21 200,392.08

Vivo Bio Tech Ltd Information

Stock PE (TTM)
17.24
Promoter Holding
42.08%
Book Value
35.121
ROCE
10.97%
ROE
5.35%
Description
  • Vivo Bio Tech is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies etc. Our experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules. Tailored and dedicated to our clients, we distinguish your development plan is as superlative as the products you bring to our testing facilities. The Biologic Research Services group at Vivo Bio Tech offers a complete line of protein services, including gene synthesis, cloning, expression and purification of recombinant proteins and monoclonal antibodies. Our scientists will team up with you to develop solution for the most difficult to deal products including purification of untagged & poorly expressed proteins. In-vitro Services offers solutions for pharmacologic, toxicological & bioanalytical investigations in drug discovery & development. Critical investigations like bacterial reverse mutation assays, chromosomal aberration, and micronucleus are specialty services by our scientists. The In-vivo Services group at Vivo Bio Tech provides both non-regulatory and regulatory IND enabling preclinical development services. We are capable of screening & evaluating molecules for various pharmacological & therapeutic properties. Specifically for oncology, our scientists can provide design & development of xenograft models for evaluation of anti-cancer agents. Further, our scientists can customize in-vivo DMPK studies to help profile your drug candidate in both rodent and non-rodent animal models. Vivo Bio has partnered with Taconic for sourcing foundation and expansion colonies of the animal models and have started in-house breeding of Specific Pathogen Free rodents.

Registered Address

Survey #349/A Pregnapur Vlge, , Gajel, Telangana, 502311

Email : investors:vivobio.com
Website : http://www.vivobio.com
Registrar

Aarthi Consultants Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 100
BSE Code : 511509
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : X
ISIN : INE380K01017

FAQ’s on Vivo Bio Tech Ltd Shares

You can buy Vivo Bio Tech Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Vivo Bio Tech Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Apr 16, 2024 04:01 PM the closing price of Vivo Bio Tech Ltd was ₹ 44.44.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Apr 16, 2024 04:01 PM, the market cap of Vivo Bio Tech Ltd stood at ₹ 66.23.

The latest PE ratio of Vivo Bio Tech Ltd as of Apr 16, 2024 04:01 PM is 17.24

The latest PB ratio of Vivo Bio Tech Ltd as of Apr 16, 2024 04:01 PM is 0.79

The 52-week high of Vivo Bio Tech Ltd share price is ₹ 56.00 while the 52-week low is ₹ 21.05

Download Our

Download App
market app